Ignite Creation Date:
2024-05-06 @ 3:03 PM
Last Modification Date:
2024-10-26 @ 1:42 PM
Study NCT ID:
NCT04512261
Status:
WITHDRAWN
Last Update Posted:
2022-07-01
First Post:
2020-07-28
Brief Title:
TOPAZ Tucatinib in COmbination With Pembrolizumab And TrastuZumab in Patients With HER2-Positive Breast Cancer Brain Metastases
Sponsor:
Reva Basho
Organization:
Cedars-Sinai Medical Center